The Oncosearch | Oncotarget

HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β Research Paper

Ken Tawara, Hannah Scott, Jacqueline Emathinger, Cody Wolf, Dollie LaJoie, Danielle Hedeen, Laura Bond, Paul Montgomery, Cheryl Jorcyk

Published Feb 14, 2019

Keywords: Oncostatin M, Interleukin-6, interleukin-1β, breast cancer, metastasis

HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β Research Paper

Ken Tawara, Hannah Scott, Jacqueline Emathinger, Cody Wolf, Dollie LaJoie, Danielle Hedeen, Laura Bond, Paul Montgomery, Cheryl Jorcyk

Published Feb 14, 2019

Keywords: Oncostatin M, Interleukin-6, interleukin-1β, breast cancer, metastasis

HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β Editorial

Ken Tawara, Hannah Scott, Jacqueline Emathinger, Cody Wolf, Dollie LaJoie, Danielle Hedeen, Laura Bond, Paul Montgomery, Cheryl Jorcyk

Published Feb 13, 2019

Keywords: Oncostatin M, Interleukin-6, interleukin-1β, breast cancer, metastasis

Intratumor heterogeneity of HMCN1 mutant alleles associated with poor prognosis in patients with breast cancer Broadcast

Chie Kikutake, Minako Yoshihara, Tetsuya Sato, Daisuke Saito, Mikita Suyama

Published Feb 12, 2019

Keywords: breast cancer, variant allele frequency, lymph node metastasis, genetic variant, next-generation sequencing

Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma Correction

Michal Alon, Rand Arafeh, Joo Sang Lee, Sanna Madan, Shelly Kalaora, Adi Nagler, Tereza Abgarian, Polina Greenberg, Eytan Ruppin, Yardena Samuels

Published Feb 12, 2019 · Vol. 10, No. 13 · pp. 1344-1344

Carbonic anhydrase 9 expression is associated with poor prognosis, tumor proliferation, and radiosensitivity of thymic carcinomas Research Paper

Yoichi Ohtaki, Kimihiro Shimizu, Reika Kawabata-Iwakawa, Navchaa Gombodorj, Bolag Altan, Susumu Rokudai, Arito Yamane, Kyoichi Kaira, Takehiko Yokobori, Toshiteru Nagashima, Kai Obayashi, Seshiru Nakazawa, Misaki Iijima, Takayuki Kosaka, Toshiki Yajima, Akira Mogi, Hiroyuki Kuwano, Ken Shirabe, Masahiko Nishiyama

Published Feb 12, 2019 · Vol. 10, No. 13 · pp. 1306-1319

Synthetic lethality of a cell-penetrating anti-RAD51 antibody in PTEN-deficient melanoma and glioma cells Priority Research Paper

Audrey Turchick, Yanfeng Liu, Weixi Zhao, Inessa Cohen, Peter M. Glazer

Published Feb 12, 2019 · Vol. 10, No. 13 · pp. 1272-1283

A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin Research Paper

Alice Gerges Geagea, Manfredi Rizzo, Abdo Jurjus, Francesco Cappello, Angelo Leone, Giovanni Tomasello, CÃ©line Gracia, Sahar Al Kattar, Liliane Massaad-Massade, Assaad Eid

Published Feb 12, 2019 · Vol. 10, No. 13 · pp. 1284-1305

Sexually dimorphic tumor suppression by small mitochondrial Arf Priority Research Perspective

Jolieke G. van Oosterwijk, Heather Tillman, Charles J. Sherr

Published Feb 8, 2019 · Vol. 10, No. 12 · pp. 1235-1237

Tumor cells containing the African-Centric S47 variant of TP53 show increased Warburg metabolism Research Paper

Thibaut Barnoud, Joshua L.D. Parris, Maureen E. Murphy

Published Feb 5, 2019 · Vol. 10, No. 11 · pp. 1217-1223

Reliable evaluation of tumor-infiltrating lymphocytes in pancreatic cancer tissue biopsies Research Paper

Yoshinori Ino, Seiji Oguro, Rie Yamazaki-Itoh, Shutaro Hori, Kazuaki Shimada, Nobuyoshi Hiraoka

Published Feb 1, 2019 · Vol. 10, No. 10 · pp. 1149-1159

LATS1/2 kinases trigger self-renewal of cancer stem cells in aggressive oral cancer Priority Research Paper

Masami Nozaki, Norikazu Yabuta, Moe Fukuzawa, Satomi Mukai, Ayumi Okamoto, Towa Sasakura, Kohshiro Fukushima, Yoko Naito, Gregory D. Longmore, Hiroshi Nojima

Published Feb 1, 2019 · Vol. 10, No. 10 · pp. 1014-1030

Therapeutic potential of nimotuzumab PEGylated-maytansine antibody drug conjugates against EGFR positive xenograft Research Paper

Siddesh V. Hartimath, Ayman El-Sayed, Amal Makhlouf, Wendy Bernhard, Carolina Gonzalez, Wayne Hill, Angel Casaco Parada, Kris Barreto, Clarence Ronald Geyer, Humphrey Fonge

Published Feb 1, 2019 · Vol. 10, No. 10 · pp. 1031-1044

Glypican-1 and glycoprotein 2 bearing extracellular vesicles do not discern pancreatic cancer from benign pancreatic diseases Research Paper

Fabrice Lucien, Vivian Lac, Daniel D. Billadeau, Ayelet Borgida, Steven Gallinger, Hon S. Leong

Published Feb 1, 2019 · Vol. 10, No. 10 · pp. 1045-1055

Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cells Research Paper

Austin R. Dosch, Xizi Dai, Alexander A. Gaidarski III, Chanjuan Shi, Jason A. Castellanos, Michael N. VanSaun, Nipun B. Merchant, Nagaraj S. Nagathihalli

Published Feb 1, 2019 · Vol. 10, No. 10 · pp. 1056-1069

Andrographolide induces DNA damage in prostate cancer cells Research Paper

Ingrid S. Forestier-RomÃ¡n, AndrÃ©s LÃ³pez-Rivas, MarÃa M. SÃ¡nchez-VÃ¡zquez, Krizia Rohena-Rivera, Gretchen Nieves-Burgos, Humberto Ortiz-Zuazaga, Carlos A. Torres-Ramos, Magaly MartÃnez-Ferrer

Published Feb 1, 2019 · Vol. 10, No. 10 · pp. 1085-1101

CD248: A therapeutic target in cancer and fibrotic diseases Review

Beverly A. Teicher

Published Jan 29, 2019 · Vol. 10, No. 9 · pp. 993-1009

Immune response characterization of endometrial cancer Research Paper

Yuexin Liu

Published Jan 29, 2019 · Vol. 10, No. 9 · pp. 982-992

Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas Research Paper

Camelia Quek, Robert V. Rawson, Peter M. Ferguson, Ping Shang, Ines Silva, Robyn P.M. Saw, Kerwin Shannon, John F. Thompson, Nicholas K. Hayward, Georgina V. Long, Graham J. Mann, Richard A. Scolyer, James S. Wilmott

Published Jan 29, 2019 · Vol. 10, No. 9 · pp. 930-941

Results of the extended analysis for cancer treatment (EXACT) trial: a prospective translational study evaluating individualized treatment regimens in oncology Research Paper

Gerald W. Prager, Matthias Unseld, Fredrik Waneck, Robert Mader, Fritz Wrba, Markus Raderer, Thorsten Fuereder, Phillip Staber, Ulrich JÃ¤ger, Markus Kieler, Daniela Bianconi, Mir Alireza Hoda, Lukas Baumann, Alexander Reinthaller, Walter Berger, Christoph Grimm, Heinz KÃ¶lbl, Maria Sibilia, Leonhard Muellauer, Christoph Zielinski

Published Jan 29, 2019 · Vol. 10, No. 9 · pp. 942-952

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β Research Paper

HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β Research Paper

HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β Editorial

Intratumor heterogeneity of HMCN1 mutant alleles associated with poor prognosis in patients with breast cancer Broadcast

Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma Correction

Carbonic anhydrase 9 expression is associated with poor prognosis, tumor proliferation, and radiosensitivity of thymic carcinomas Research Paper

Synthetic lethality of a cell-penetrating anti-RAD51 antibody in PTEN-deficient melanoma and glioma cells Priority Research Paper

A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin Research Paper

Sexually dimorphic tumor suppression by small mitochondrial Arf Priority Research Perspective

Tumor cells containing the African-Centric S47 variant of TP53 show increased Warburg metabolism Research Paper

Reliable evaluation of tumor-infiltrating lymphocytes in pancreatic cancer tissue biopsies Research Paper

LATS1/2 kinases trigger self-renewal of cancer stem cells in aggressive oral cancer Priority Research Paper

Therapeutic potential of nimotuzumab PEGylated-maytansine antibody drug conjugates against EGFR positive xenograft Research Paper

Glypican-1 and glycoprotein 2 bearing extracellular vesicles do not discern pancreatic cancer from benign pancreatic diseases Research Paper

Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cells Research Paper

Andrographolide induces DNA damage in prostate cancer cells Research Paper

CD248: A therapeutic target in cancer and fibrotic diseases Review

Immune response characterization of endometrial cancer Research Paper

Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas Research Paper

Results of the extended analysis for cancer treatment (EXACT) trial: a prospective translational study evaluating individualized treatment regimens in oncology Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β Research Paper

HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β Research Paper

HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β Editorial

Intratumor heterogeneity of HMCN1 mutant alleles associated with poor prognosis in patients with breast cancer Broadcast

Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma Correction

Carbonic anhydrase 9 expression is associated with poor prognosis, tumor proliferation, and radiosensitivity of thymic carcinomas Research Paper

Synthetic lethality of a cell-penetrating anti-RAD51 antibody in PTEN-deficient melanoma and glioma cells Priority Research Paper

A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin Research Paper

Sexually dimorphic tumor suppression by small mitochondrial Arf Priority Research Perspective

Tumor cells containing the African-Centric S47 variant of TP53 show increased Warburg metabolism Research Paper

Reliable evaluation of tumor-infiltrating lymphocytes in pancreatic cancer tissue biopsies Research Paper

LATS1/2 kinases trigger self-renewal of cancer stem cells in aggressive oral cancer Priority Research Paper

Therapeutic potential of nimotuzumab PEGylated-maytansine antibody drug conjugates against EGFR positive xenograft Research Paper

Glypican-1 and glycoprotein 2 bearing extracellular vesicles do not discern pancreatic cancer from benign pancreatic diseases Research Paper

Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cells Research Paper

Andrographolide induces DNA damage in prostate cancer cells Research Paper

CD248: A therapeutic target in cancer and fibrotic diseases Review

Immune response characterization of endometrial cancer Research Paper

Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas Research Paper

Results of the extended analysis for cancer treatment (EXACT) trial: a prospective translational study evaluating individualized treatment regimens in oncology Research Paper